Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood

American Journal of Clinical Pathology

Volumn 115, Issue 6, 2001, Pages 885-892

  Jones, Dan ^a,b   Dang, Nam H ^a   Duvic, Madeleine ^a   Washington, LaBaron T ^a   Huh, Yang O ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Box 72 ^*  (United States)

Author keywords

Flow cytometry; Mycosis fungoides; T cell lymphoma; Tumor markers

Indexed keywords

CD4 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; DIPEPTIDYL PEPTIDASE IV;

ANTIGEN EXPRESSION; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; LYMPHOCYTE SUBPOPULATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; SEZARY SYNDROME; T CELL LYMPHOMA; TUMOR CELL;

ANTIGENS, CD26; ANTIGENS, CD7; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; FLOW CYTOMETRY; HUMANS; LYMPHOMA, T-CELL; LYMPHOPROLIFERATIVE DISORDERS; MYCOSIS FUNGOIDES; SEZARY SYNDROME; T-LYMPHOCYTE SUBSETS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035017185     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/U1Y6-J4AG-5M4M-7AYV     Document Type: Article

References (32)

1. Bakels V, van Oostveen JW, Gordijn RL, et al. Frequency and prognostic significance of clonal T-cell receptor beta-gene rearrangements in the peripheral blood of patients with mycosis fungoides. Arch Dermatol. 1992;128:1602-1607.
2. Fraser-Andrews EA, Woolford AJ, Russell-Jones R, et al. Detection of a peripheral blood t cell clone is an independent prognostic marker in mycosis fungoides. J Invest Dermatol. 2000;114:117-121.
3. Dommann SN, Dommann-Scherrer CC, Dours-Zimmermann MT, et al. Clonal disease in extracutaneous compartments in cutaneous T-cell lymphomas: a comparative study between cutaneous T-cell lymphomas and pseudo lymphomas. Arch Dermatol Res. 1996;288:163-167.
4. Laetsch B, Haffner AC, Dobbeling U, et al. CD4+/CD7- T cell frequency and polymerase chain reaction-based clonality assay correlate with stage in cutaneous T cell lymphomas. J Invest Dermatol. 2000;114:107-111.
5. Muche JM, Lukowsky A, Asadullah K, et al. Demonstration of frequent occurrence of clonal T cells in the peripheral blood of patients with primary cutaneous T-cell lymphoma. Blood. 1997;90:1636-1642.
6. Muche JM, Lukowsky A, Heim J, et al. Demonstration of frequent occurrence of clonal T cells in the peripheral blood but not in the skin of patients with small plaque parapsoriasis. Blood. 1999;94:1409-1417.
7. Bogen SA, Pelley D, Charif M, et al. Immunophenotypic identification of Sézary cells in peripheral blood. Am J Clin Pathol. 1996;106:739-748.
8. Harmon CB, Witzig TE, Katzmann JA, et al. Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses. J Am Acad Dermatol. 1996;35:404-410.
9. Scala E, Russo G, Cadoni S, et al. Skewed expression of activation, differentiation and homing-related antigens in circulating cells from patients with cutaneous T cell lymphoma associated with CD7- T helper lymphocytes expansion. J Invest Dermatol. 1999;113:622-627.
10. Borowitz MJ, Weidner A, Olsen EA, et al. Abnormalities of circulating T-cell subpopulations in patients with cutaneous T-cell lymphoma: cutaneous lymphocyte-associated antigen expression on T cells correlates with extent of disease. Leukemia. 1993;7:859-863.
11. Moll M, Reinhold U, Kukel S, et al. CD7-negative helper T cells accumulate in inflammatory skin lesions. J Invest Dermatol. 1994;102:328-332.
12. Dang NH, Torimoto Y, Shimamura K, et al. 1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation. J Immunol. 1991;147:2825-2832.
13. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835-3849.
14. Dang NH, Torimoto Y, Sugita K, et al. Cell surface modulation of CD26 by anti-1F7 monoclonal antibody: analysis of surface expression and human T cell activation. J Immunol. 1990;145:3963-3971.
15. Jones D, O'Hara C, Kraus M, et al. Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Blood. 2000;96:685-690.
16. Bank I, Rapman E, Shapiro R, et al. The epidermotropic mycosis fungoides associated alpha1beta1 integrin (VLA-1, CD49a/CD29) is primarily a collagen IV receptor on malignant T cells. J Cutan Pathol. 1999;26:65-71.
17. Lu D, Duvic M, Medeiros LJ, et al. The T-cell chemokine receptor CXCR 3 is expressed highly in low-grade mycosis fungoides. Am J Clin Pathol. 2001;115:413-421.
18. Kamarashev J, Burg G, Kempf W, et al. Comparative analysis of histological and immunohistological features in mycosis fungoides and Sézary syndrome. J Cutan Pathol. 1998;25:407-412.
19. Fuhlbrigge RC, Kieffer JD, Armerding D, et al. Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature. 1997;389:978-981.
20. Picker LJ, Michie SA, Rott LS, et al. A unique phenotype of skin-associated lymphocytes in humans: preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. Am J Pathol. 1990;136:1053-1068.
21. Dworzak MN, Froschl G, Printz D, et al. Skin-associated lymphocytes in the peripheral blood of patients with atopic dermatitis: signs of subset expansion and stimulation. J Allergy Clin Immunol. 1999;103:901-906.
22. Jones D, Benjamin RJ, Shahsafaei A, et al. The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia. Blood. 2000;95:627-632.
23. Santamaria Babi LF, Picker LJ, Perez Soler MT, et al. Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen. J Exp Med. 1995;181:1935-1940.
24. Armerding D, Kupper TS. Functional cutaneous lymphocyte antigen can be induced in essentially all peripheral blood T lymphocytes. Int Arch Allergy Immunol. 1999;119:212-222.
25. Reinhold U, Pawelec G, Fratila A, et al. Phenotypic and functional characterization of tumor infiltrating lymphocytes in mycosis fungoides: continuous growth of CD4+ CD45R+ T- cell clones with suppressor-inducer activity. J Invest Dermatol. 1990;94:304-309.
26. Schiavon V, Roth P, Bolton WE, et al. Lymphocytes subsets in normal individuals: analysis by four color immunofluorescence and flow cytometry on whole blood. Tissue Antigens. 1996;48(4 pt 1):312-318.
27. Buhling F, Kunz D, Reinhold D, et al. Expression and functional role of dipeptidyl peptidase IV (CD26) on human natural killer cells. Nat Immun. 1994;13:270-279.
28. Ruiz P, Zacharievich N, Shenkin M. Multicolor cytoenzymatic evaluation of dipeptidyl peptidase IV (CD26) function in normal and neoplastic human T-lymphocyte populations. Clin Diagn Lab Immunol. 1998;5:362-368.
29. Ruiz P, Mailhot S, Delgado P, et al. CD26 expression and dipeptidyl peptidase IV activity in an aggressive hepatosplenic T-cell lymphoma. Cytometry. 1998;34:30-35.
30. Kondo S, Kotani T, Tamura K, et al. Expression of CD26/ dipeptidyl peptidase IV in adult T cell leukemia/lymphoma (ATLL). Leuk Res. 1996;20:357-363.
31. Carbone A, Cozzi M, Gloghini A, et al. CD26/dipeptidyl peptidase IV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset of T-cell non-Hodgkins lymphomas. Hum Pathol. 1994;25:1360-1365.
32. Klobusicka M, Babusikova O. CD26 and DPP IV expression in T acute lymphoblastic leukemia cells: immunocytochemistry and enzyme cytochemistry. Gen Physiol Biophys. 1999;18(suppl 1):34-37.